| Bioactivity | GSK854 is a potent Inhibitor of Troponin I-Interacting Kinase (TNNI3K). GSK854 is a suitable lead for identifying new cardiac medicines and have been employed as in vivo tools in investigational studies aimed at defining the role of TNNI3K within heart failure[1]. | ||||||||||||
| Name | GSK854 | ||||||||||||
| CAS | 1316059-00-3 | ||||||||||||
| Formula | C18H19ClN6O4S2 | ||||||||||||
| Molar Mass | 482.96 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Philp J, et al. 4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors. J Med Chem. 2018;61(7):3076-3088. |
GSK854
CAS: 1316059-00-3 F: C18H19ClN6O4S2 W: 482.96
GSK854 is a potent Inhibitor of Troponin I-Interacting Kinase (TNNI3K). GSK854 is a suitable lead for identifying new ca
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.